| Product Code: ETC7220271 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France HER2 Testing Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France HER2 Testing Market Revenues & Volume, 2021 & 2031F |
3.3 France HER2 Testing Market - Industry Life Cycle |
3.4 France HER2 Testing Market - Porter's Five Forces |
3.5 France HER2 Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.6 France HER2 Testing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 France HER2 Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 France HER2 Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2-positive breast cancer in France |
4.2.2 Growing adoption of personalized medicine and targeted therapies |
4.2.3 Rising awareness about the importance of HER2 testing in treatment decisions |
4.3 Market Restraints |
4.3.1 High cost associated with HER2 testing procedures |
4.3.2 Limited accessibility to advanced HER2 testing technologies in certain regions of France |
5 France HER2 Testing Market Trends |
6 France HER2 Testing Market, By Types |
6.1 France HER2 Testing Market, By Technique |
6.1.1 Overview and Analysis |
6.1.2 France HER2 Testing Market Revenues & Volume, By Technique, 2021- 2031F |
6.1.3 France HER2 Testing Market Revenues & Volume, By Fluorescence In Situ Hybridization, 2021- 2031F |
6.1.4 France HER2 Testing Market Revenues & Volume, By Dual-Probe, 2021- 2031F |
6.1.5 France HER2 Testing Market Revenues & Volume, By Single-Probe, 2021- 2031F |
6.1.6 France HER2 Testing Market Revenues & Volume, By Chromogenic In Situ Hybridization (CISH), 2021- 2031F |
6.1.7 France HER2 Testing Market Revenues & Volume, By Silver-Enhanced In Situ Hybridization, 2021- 2031F |
6.2 France HER2 Testing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 France HER2 Testing Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 France HER2 Testing Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.3 France HER2 Testing Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 France HER2 Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 France HER2 Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 France HER2 Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 France HER2 Testing Market Import-Export Trade Statistics |
7.1 France HER2 Testing Market Export to Major Countries |
7.2 France HER2 Testing Market Imports from Major Countries |
8 France HER2 Testing Market Key Performance Indicators |
8.1 Average turnaround time for HER2 test results |
8.2 Number of laboratories offering HER2 testing services |
8.3 Rate of reimbursement for HER2 testing by healthcare payers |
9 France HER2 Testing Market - Opportunity Assessment |
9.1 France HER2 Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.2 France HER2 Testing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 France HER2 Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 France HER2 Testing Market - Competitive Landscape |
10.1 France HER2 Testing Market Revenue Share, By Companies, 2024 |
10.2 France HER2 Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here